<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    TCR2 Therapeutics Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About TCR2 Therapeutics Inc.

    TCR² is an innovative immunotherapy company developing the next generation of T cell therapies for patients suffering from cancer. Our proprietary TRuC™ (TCR Fusion Construct) T cells – a novel T cell therapy platform – reprogram the natural T cell receptor complex to recognize and kill cancer cells using the full power of T cell signaling pathways independent of HLA. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $347,800,000
    • SIC CODE
      2836
    • NIN CODE
      ####
    • LEADERSHIP
      Garry Menzel, PhD and MBA
    • FOUNDED
      2015
    • EMPLOYEES
      20
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Scottline Healthcare Solutions, Inc

    Scottline Healthcare Solutions, Inc

    Scottline helps healthcare organizations establish a secure, agile digital infrast...

    Scottline helps healthcare organizations establ...

    Filing Type:    RARD
    Heska Corporation

    Heska Corporation

    Heska Corporation (NASDAQ: HSKA – News) manufactures, develops and sells advance...

    Heska Corporation (NASDAQ: HSKA – News) manuf...

    Filing Type:    PU
    Jazz Pharmaceuticals plc

    Jazz Pharmaceuticals plc

    Jazz Pharmaceuticals plc (NASDAQ: JAZZ) is a global biopharmaceutical company that...

    Jazz Pharmaceuticals plc (NASDAQ: JAZZ) is a gl...

    Filing Type:    PU
    Viela Bio, Inc.

    Viela Bio, Inc.

    Viela is dedicated to the development and commercialization of novel, life-changin...

    Viela is dedicated to the development and comme...

    Filing Type:    PU
    Acer Therapeutics Inc.

    Acer Therapeutics Inc.

    Acer is a pharmaceutical company focused on the acquisition, development and comme...

    Acer is a pharmaceutical company focused on the...

    Filing Type:    PU
    Global Blood Therapeutics, Inc.

    Global Blood Therapeutics, Inc.

    Global Blood Therapeutics, Inc. (GBT) is a clinical-stage biopharmaceutical dedica...

    Global Blood Therapeutics, Inc. (GBT) is a clin...

    Filing Type:    PU
    Marker Therapeutics, Inc.

    Marker Therapeutics, Inc.

    We are a clinical-stage immuno-oncology company specializing in the development an...

    We are a clinical-stage immuno-oncology company...

    Filing Type:    PU
    OncoSec Medical Incorporated

    OncoSec Medical Incorporated

    OncoSec Medical Incorporated is a clinical-stage biotechnology company focused on ...

    OncoSec Medical Incorporated is a clinical-stag...

    Filing Type:    PU
    Trillium Therapeutics Inc.

    Trillium Therapeutics Inc.

    Trillium Therapeutics Inc. is a clinical stage immuno-oncology company developing ...

    Trillium Therapeutics Inc. is a clinical stage ...

    Filing Type:    PU
    Oncternal Therapeutics, Inc.

    Oncternal Therapeutics, Inc.

    Oncternal Therapeutics is a clinical-stage oncology company developing a diverse p...

    Oncternal Therapeutics is a clinical-stage onco...

    Filing Type:    PU
    Cyclacel Pharmaceuticals, Inc.

    Cyclacel Pharmaceuticals, Inc.

    Cyclacel's founding scientist, Professor Sir David Lane, a globally recognized aut...

    Cyclacel's founding scientist, Professor Sir Da...

    Filing Type:    PU
    iCAD inc.

    iCAD inc.

    iCAD, Inc. an industry-leading provider of advanced image analysis, workflow solut...

    iCAD, Inc. an industry-leading provider of adva...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.